Search for: "Hoffmann v. Hoffmann" Results 281 - 300 of 463
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Apr 2013, 7:31 am by Daniel Schwartz
  However, the case is certain to prove to be a key FLSA precedent, the first since the Supreme Court’s 1989 ruling in Hoffmann-LaRoche v. [read post]
5 Jul 2010, 10:08 pm by Rosalind English
Along with the contributions of Lord Judge, Lord Hoffmann and Lady Justice Arden, this address forms part of an elegant but increasingly intense debate that reflects unease about Strasbourg. [read post]
4 Jun 2024, 11:36 am by Francis Pileggi
The justices unanimously reversed the Court of Chancery’s decision that the transaction met the standard Khan v. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
18 Dec 2009, 3:04 am
Following the IPKat's earlier post on the German Bundesgerichtshof decision on Lundbeck's escitalopram patent, the Kat's plea for an English translation of the German original has been kindly answered by German IP practice Hoffmann Eitle. [read post]
16 Dec 2013, 8:05 pm by Gilles Cuniberti
To be precise, seven decisions of Areios Pagos have applied the findings of the ECJ in the case FBTO Schadeverzekeringen NV v Jack Odenbreit. [read post]
7 Jun 2011, 11:06 am by Lawrence B. Ebert
Hoffmann-La Roche Inc., 541 F.3d. 1115, 1126 (Fed. [read post]
15 Jun 2011, 12:50 am by Matthew Flinn
I readily acknowledge that, as Lord Hoffmann pointed out in Piglowska v Piglowski [1999] 1 WLR 1360, 1372, reasons should be read on the assumption that, unless she has demonstrated the contrary, the decision maker knew how she should perform her functions and which matters she should take into account. [read post]
19 Mar 2014, 9:00 am by Paula Bremner
It has been 15 years since the last brand v brand challenge of a biologic patent in Canada. [read post]
26 Mar 2014, 3:25 pm
However, the CJEU's decision in Roche v Primus rejected this strategy. [read post]
28 Jun 2014, 4:49 am
No…On the question of the implied term, HHJ Hacon found Lord Hoffmann’s comments in Attorney General of Belize v Belize Telecom Ltd [2009] UKPC 10(a judgment of the Board of the Privy Council) instructive. [read post]
17 Nov 2020, 11:15 am by Alex Woolgar
Arnold LJ focused on a point made clear by Lord Hoffmann in Douglas v Hello! [read post]
15 Jun 2011, 4:56 am by Marie Louise
(Patent Docs) Xeloda (Capecitabine) – US: Patent infringement complaint filed in response to Para IV certification: Hoffmann-La Roche Inc. v. [read post]
30 Jul 2009, 8:45 pm
Hoffmann-La Roche, Inc., 541 F.3d 1115, 1129 (Fed. [read post]